Ascendis Pharma
ASND
ASND
34 hedge funds and large institutions have $646M invested in Ascendis Pharma in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 35 → 34 (-1)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
34
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$18M | |
| 2 | +$15.4M | |
| 3 | +$12.7M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$11.1M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$10.9M |
Top Sellers
| 1 | -$14.2M | |
| 2 | -$2.8M | |
| 3 | -$2.6M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$2.15M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
-$665K |